Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aryl hydrocarbon receptor (AHR) activator compounds as cancer therapeutics

Aryl hydrocarbon receptor (AHR) activator compounds as cancer therapeutics

US Patent 12358918 · Granted Jul 15, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cancers with loss of chromosome 16Q and/or low expression of metallothionein pro2025
Cancers with loss of chromosome 16Q and/or low expression of metallothionein pro2025
Cancers with loss of chromosome 16Q and/or low expression of metallothionein pro2025
Cancers with loss of chromosome 16Q and/or low expression of metallothionein pro2025
Tepoxalin targeting of ABCB1 overexpressing cancers2025
Tepoxalin targeting of ABCB1 overexpressing cancers2025
Tepoxalin targeting of ABCB1 overexpressing cancers2025
Tepoxalin targeting of ABCB1 overexpressing cancers2025
DNA damage response signature guided rational design of CRISPR-based systems and2025
3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridi2025
Agents for reversing toxic proteinopathies2024
Agents for reversing toxic proteinopathies2024